US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

108.43

-3.3047-2.96%

Post-market: 108.430.00000.00%19:30 EDT

Volume:7K

Turnover:731.00K

Market Cap:94.33M

PE:- -

High:110.00

Open:110.00

Low:107.04

Close:111.73

52wk High:126.40

52wk Low:55.34

Shares:870.00K

Float Shares:870.00K

Volume Ratio:0.46

T/O Rate:0.78%

Dividend:0.32

Dividend Rate:0.30%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Political and General News Events from August 25

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus

Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential

Political and General News Events from August 24

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.

Funds: What a Top Biotech Fund is Buying Now

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Moderna Inc. Stock Advances 8.9%, Outperforms Peers

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BIB/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"ProShares Ultra Nasdaq Biotechnology","latestPrice":108.43,"timestamp":1789502400000,"preClose":111.7347,"halted":0,"volume":6749,"hourTrading":{"tag":"盘后","latestPrice":108.43,"preClose":108.43,"latestTime":"19:30 EDT","volume":12,"amount":1301.16,"timestamp":1789515007137,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02957630888166341,"floatShares":870000,"shares":870000,"eps":0,"marketStatus":"Closed","change":-3.3047,"latestTime":"09-15 16:00:00 EDT","open":110,"high":110,"low":107.035,"amount":731000.293114,"amplitude":0.026536,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":111.7347,"sharesOutstanding":1040000,"nav":111.7314,"aum":93854376,"dividendRate":0.002988,"bidAskSpread":0.002339,"postHourTrading":{"tag":"盘后","latestPrice":108.43,"preClose":108.43,"latestTime":"19:30 EDT","volume":12,"amount":1301.16,"timestamp":1789515007137,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.460356,"impliedVol":0.491,"impliedVolPercentile":0.7809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":870000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.460356,"shares":870000,"dividePrice":0.324,"high":110,"amplitude":0.026536,"preClose":111.7347,"low":107.035,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":108.43,"eps":0,"divideRate":0.002988,"volume":6749,"delay":0,"ttmEps":0,"open":110,"prevYearClose":79.7794,"prevWeekClose":109.7741,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":115.08,"twentyDayClose":109.8842,"sixtyDayClose":85.0227},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662796495","title":"Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796495","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796495?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:32","pubTimestamp":1787733120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 2.1% to 5.74 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 25652.97.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 37% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.2% and Amgen Inc. remained unchanged.Trading volume totaled 180.5 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BBH","IE00B2B36J28.USD","AMGN","LU1061106388.HKD","LU0889565916.HKD","BK4566","IE00BZ08YT58.USD","BK1191","LU0058720904.USD","HK0000165453.HKD","IE0009355771.USD","BK4588","IBB","IE00BZ08YR35.GBP","LU0109394709.USD","LU0868494617.USD","BIB","LU1571399168.USD","LU1057294990.SGD","LU1023059063.AUD","IE00BZ08YS42.EUR","LU2089984988.USD","PJP","LU2242652126.USD","LU2468319806.SGD","BK4534","TBXU","IE0002141913.USD","IE00BFTCPJ56.SGD","BK1589","BK1521","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU2242646821.SGD","PBE","BK4599","IBBQ","SG9999001440.SGD","BK4581","01177","BK1515","BK4533","BK4139","LU0122379950.USD","LU0320765992.SGD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662175230","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662175230","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662175230?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:35","pubTimestamp":1787690100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rose 1.38% to $148.77 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40.This was the stock's third consecutive day of gains.Gilead Sciences Inc. closed 5.42% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.53% to $273.14, Pfizer Inc.  rose 2.15% to $28.57, and Abbott Laboratories  fell 0.46% to $116.13.Trading volume  remained 2.7 million below its 50-day average volume of 7.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","LU1585245621.USD","BMED","LU1037948897.HKD","LU1430594728.SGD","LU1066051498.USD","LU1037948541.HKD","LU0965509010.AUD","IE00BKVL7J92.USD","TBXU","LU1571399168.USD","LU0234570918.USD","LU1934455194.USD","LU0320765992.SGD","LU1674673691.USD","LU2324357040.USD","BK4583","SG9999015986.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU0965509283.SGD","LU1061106388.HKD","BK4568","BK4585","LU0058720904.USD","LU0122379950.USD","LU0861579265.USD","LU0889565916.HKD","LU1023059063.AUD","BK4532","LU1839511570.USD","LU0289739699.SGD","BK4588","LU0859254822.USD","LU2087621335.USD","IE0002270589.USD","LU1934455863.HKD","IE00BSNM7G36.USD","LU0965508806.USD","TMED","MEDI","LU0109394709.USD","LU1066053197.SGD","SG9999015945.SGD","SG9999015978.USD","IBBQ","BK4139","LU1057294990.SGD","BK4550","LU0882574055.USD","LU1778281490.HKD","IBB","BK4566","LU0114720955.EUR","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU0823416689.USD","BK4578","LU1674673428.USD","LU0965509101.SGD","LU2089984988.USD","LU2357627491.SGD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BIB","LU1934455277.USD","BBH","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752593","title":"Moderna Inc. Stock Rallies 14.4%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752593?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:33","pubTimestamp":1787689980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. surged 14.4% to $158.83 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.7% to 26,151.30 and the Dow Jones Industrial Average rising 0.3% to 53,577.40.Moderna Inc. closed 10.1% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.5% to $273.14, Pfizer Inc. rose 2.1% to $28.57, and Gilead Sciences Inc. rose 1.38% to $148.77.Trading volume totaled 48.9 million, compared to the 50-day average of 15.2 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","IBB","IE00B3T34201.USD","MRNX","LU1023059063.AUD","SG9999015952.SGD","IE00B7SZLL34.SGD","BK4583","LU1037948541.HKD","LU0058720904.USD","LGHT","SG9999015978.USD","IE00BSNM7G36.USD","MRNY","TBXU","TMED","LU2089984988.USD","MRNA","SG9999015986.USD","LU1430594728.SGD","LU1674673428.USD","GILD","WDNA","IDNA","LU0965509101.SGD","LU0965509283.SGD","IE0002270589.USD","LU2468319806.SGD","BK4533","LU0320765992.SGD","BK4534","LU1061106388.HKD","IE00B19Z3581.USD","LU0965509010.AUD","LU0859254822.USD","LU1037948897.HKD","BK4566","BMED","BK4588","IBBQ","BK4568","LU0114720955.EUR","LU0889565916.HKD","BK4548","BBH","LU1057294990.SGD","BIB","MEDI","LU0823416689.USD","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662370257","title":"Political and General News Events from August 25","url":"https://stock-news.laohu8.com/highlight/detail?id=2662370257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662370257?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:25","pubTimestamp":1787664343,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 25Aug 25 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4N44M0UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU1061106388.HKD","LU2242646821.SGD","LU2112291526.USD","BK4588","BK4599","IE00BJJMRZ35.SGD","LU0122379950.USD","IE00B4R5TH58.HKD","BK4585","IBB","LU2242652126.USD","BK4581","PBE","LU0058720904.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU1571399168.USD","LU1983299246.USD","LU2468319806.SGD","BBH","IBBQ","BK4566","BIB","LU0109394709.USD","BK4533","IE00BJT1NW94.SGD","IE00B2B36J28.USD","PJP","TBXU","LU0868494617.USD","AMGN","LU0289739699.SGD","LU1023059063.AUD","IE0002141913.USD","BK4534","IE0009355771.USD","LU0320765992.SGD","SG9999001440.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662786682","title":"Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2662786682","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662786682?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:37","pubTimestamp":1787632638,"startTime":"0","endTime":"0","summary":"Viavi Solutions (VIAV) has launched Vertex 6.0, a new version of its channel emulation platform designed for 6G and Wi-Fi 7/8 testing. Investors are assessing what this expanded wireless testing capability might imply for the stock.\nSee our latest analysis for Viavi Solutions.\nThe Vertex 6.0 launch arrives after a sharp pullback in Viavi Solutions' share price, with the stock down 20.13% over the past week and 31.31% over 90 days. However, year to date the share price return is 103.58% and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/viavi-solutions-viav-could-be-40-undervalued-on-vertex-60-la","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/viavi-solutions-viav-could-be-40-undervalued-on-vertex-60-la","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IDNA","LU0757428866.USD","BK4020","LU2362541273.HKD","LU2065170008.USD","IE00B19Z3581.USD","LU1585245621.USD","IE00BFTCPJ56.SGD","LU0079474960.USD","IBB","LU2468319806.SGD","IE00BZ9MQY76.HKD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","GNMX","BK4567","LU0289739699.SGD","IE0002141913.USD","LU2362540622.SGD","LU2065171311.SGD","LU2089984988.USD","LU1093756325.SGD","BK4023","BBH","IBBQ","LU2417539215.USD","LU2065169927.USD","TBXU","LU0234570918.USD","LU0205194284.USD","LU2462157665.USD","LU1093756168.USD","LU1069344957.HKD","VERX","LU2237438978.USD","BIB","IE00B19Z9P08.USD","IE0009355771.USD","VIAV","IE0002270589.USD","BK4139","VRTX","LU1778281490.HKD","LU0240877869.USD","IE00B894F039.SGD","LU2236285917.USD","PBE","SG9999013999.USD","LU1559883803.SGD","VIAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820617","title":"Moderna Inc. Stock Slides 4.3%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820617?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:34","pubTimestamp":1787603640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 4.3% to $138.89 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.3% to 53,417.16 and the NASDAQ Composite Index falling 0.8% to 25,980.19.Moderna Inc. closed 21.4% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.0% to $273.04, Pfizer Inc. fell 0.4% to $27.97, and Gilead Sciences Inc. rose 0.42% to $146.74.Trading volume totaled 31.3 million, compared to the 50-day average of 14.7 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IE00B3T34201.USD","TMED","BK4578","WDNA","LU0234570918.USD","MRNX","LU0859254822.USD","LU1057294990.SGD","MRNY","LU0122379950.USD","SG9999015986.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU1585245621.USD","IBBQ","IE00B19Z3581.USD","LU1037948541.HKD","GILD","LU2324357040.USD","BIB","BK4568","LU0114720955.EUR","LU0965509283.SGD","LU2357627491.SGD","LU1934455277.USD","IE0002270589.USD","LU0289739699.SGD","LU1061106388.HKD","LU2468319806.SGD","BK4532","TBXU","IE00BSNM7G36.USD","BK4139","IDNA","LU2089984988.USD","LU1839511570.USD","MEDI","BK4534","BMED","GNOM","LU0109394709.USD","BK4548","LU0320765992.SGD","SG9999015952.SGD","LU1037948897.HKD","LGHT","MRNA","BK4566","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662206197","title":"Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206197","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206197?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:34","pubTimestamp":1787603640,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rallied 1.03% to $443.84 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.26% to 53,417.16 and the S&P 500 Index  falling 0.28% to 7,652.86.This was the stock's second consecutive day of gains.Amgen Inc. hit a new 52-week high, surpassing its previous peak of $443.20, which the company reached on August 19th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 1.04% to $273.04, Pfizer Inc.  fell 0.36% to $27.97, and AbbVie Inc.  fell 0.17% to $264.52.Trading volume  remained 382,792 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 24, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","LU1983299246.USD","TBXU","IE0002141913.USD","04332","IE00B2B36J28.USD","LU0289739699.SGD","BK4139","IE00B4R5TH58.HKD","BK4533","BK4581","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0889565916.HKD","LU0122379950.USD","PBE","BIB","LU2242646821.SGD","IBBQ","LU0058720904.USD","BBH","BK4585","LU0868494617.USD","BK4566","IBB","LU2112291526.USD","BK4534","BK4588","LU0320765992.SGD","LU2242652126.USD","LU1057294990.SGD","LU1061106388.HKD","SG9999001440.SGD","LU0109394709.USD","AMGN","LU1571399168.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU2089984988.USD","LU1023059063.AUD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205709","title":"Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205709","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205709?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601693,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutics wins FDA orphan drug status for gamgertamig in pemphigusFDA granted orphan drug designation to gamgertamig for pemphigus.The drug already holds FDA fast track and orphan stat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL5cnKbj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","IE00B64PRP62.GBP","MEDI","SG9999015978.USD","IE00BQXX3F31.USD","LU2210150020.SGD","LU1430594728.SGD","BIB","IE00BKPKM429.USD","LU2089984988.USD","GILD","LU1037948541.HKD","LU0289739699.SGD","SG9999014013.SGD","BK4566","IE00BN0W2W23.USD","IE00BZ1G4Q59.USD","IBBQ","BK4578","LU0965508806.USD","LU2087621335.USD","BK4139","LU1023059063.AUD","LU0320765992.SGD","LU2210149790.SGD","LU0861579265.USD","LU0122379950.USD","LU0234570918.USD","BK4568","LU1674673691.USD","BK4550","BMED","TBXU","IE0002270589.USD","BBH","IE00BKVL7J92.USD","TMED","IE00B19Z3B42.SGD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","LU0859254822.USD","BCDF","SG9999014039.USD","LU2095319765.USD","NDAQ","IBB","LU0965509010.AUD","SG9999015952.SGD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662729270","title":"Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2662729270","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662729270?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:31","pubTimestamp":1787589063,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. is moving ahead with MARITIME-2-EXTENSION, a Phase 3 trial that t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-extends-maritide-study-in-obesity-and-diabetes-keeping-investor-focus-on-long-term-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-extends-maritide-study-in-obesity-and-diabetes-keeping-investor-focus-on-long-term-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","TBXU","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","LU2112291526.USD","IBBQ","LU0122379950.USD","LU1571399168.USD","LU0889565916.HKD","AMGN","PJP","BK4533","BK4599","IE0009355771.USD","SG9999001440.SGD","LU0289739699.SGD","LU2242652126.USD","BK4566","IBB","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4534","LU2089984988.USD","BIB","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4139","LU0109394709.USD","LU0320765992.SGD","BK4585","PBE","LU0058720904.USD","LU2468319806.SGD","PSIL","LU1061106388.HKD","BK4588","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1983299246.USD","BBH","LU2242646821.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271512","title":"Political and General News Events from August 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271512?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:19","pubTimestamp":1787577552,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 24Aug 24 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L0XV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","IE00B2B36J28.USD","LU0109394709.USD","LU0289739699.SGD","LU2468319806.SGD","LU0868494617.USD","BK4534","LU2089984988.USD","IE0002141913.USD","IE0009355771.USD","LU2112291526.USD","PJP","IE00BFTCPJ56.SGD","BK4599","LU1061106388.HKD","IE00BJT1NW94.SGD","BBH","LU0320765992.SGD","TBXU","SG9999001440.SGD","LU2242646821.SGD","BK4581","LU1983299246.USD","BK4585","IBB","BK4139","IBBQ","BK4533","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1057294990.SGD","LU0058720904.USD","IE00B4R5TH58.HKD","BK4566","LU0122379950.USD","PBE","BIB","AMGN","LU1571399168.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278374","title":"EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278374?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567503,"startTime":"0","endTime":"0","summary":"EU Commission approves Gilead Trodelvy-Keytruda combo for first-line PD-L1+ metastatic TNBCEuropean Commission granted marketing authorization for Trodelvy with Merck’s Keytruda in first-line metastat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4gZS8y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0965508806.USD","LU1934455194.USD","BK4583","LU1934455277.USD","BK4585","LU1934455863.HKD","LU0965509283.SGD","IE0002270589.USD","BMED","SG9999015952.SGD","LU1037948897.HKD","LU1430594728.SGD","LU2468319806.SGD","IBB","MEDI","LU2357627491.SGD","LU2089984988.USD","LU0859254822.USD","IE00B3T34201.USD","TBXU","BK4566","LU0114720955.EUR","LU0882574055.USD","SG9999015986.USD","BBH","LU1057294990.SGD","LU1778281490.HKD","LU0861579265.USD","IBBQ","LU0109394709.USD","LU1066051498.USD","SG9999015978.USD","GILD","LU0320765992.SGD","LU1571399168.USD","TMED","LU1023059063.AUD","LU0965509010.AUD","LU0823416689.USD","BK4550","LU0289739699.SGD","LU1585245621.USD","LU0965509101.SGD","LU0058720904.USD","LU1037948541.HKD","LU1061106388.HKD","IE00B19Z3581.USD","LU1674673691.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661325278","title":"Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc","url":"https://stock-news.laohu8.com/highlight/detail?id=2661325278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661325278?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066053197.SGD","BK4585","BK4139","IE00B3T34201.USD","LU1585245621.USD","LU0965509101.SGD","LU1037948897.HKD","TBXU","LU0289739699.SGD","LU0320765992.SGD","LU1934455194.USD","BK4550","IBBQ","LU0889565916.HKD","LU1057294990.SGD","IBB","LU2357627491.SGD","IE00BSNM7G36.USD","LU0234570918.USD","LU1674673691.USD","LU1674673428.USD","SG9999015945.SGD","BK4568","LU1061106388.HKD","LU0965508806.USD","SG9999015978.USD","BK4588","GILD","BK4566","LU0965509010.AUD","LU0058720904.USD","BMED","IE00B7SZLL34.SGD","TMED","BIB","SG9999015986.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD","LU2324357040.USD","LU1066051498.USD","LU1023059063.AUD","LU1934455863.HKD","SG9999015952.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","BBH","LU0965509283.SGD","MEDI","LU1934455277.USD","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278323","title":"European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278323?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1674673428.USD","IBBQ","BIB","LU0882574055.USD","GILD","LU0122379950.USD","IE00B19Z3581.USD","LU2087621335.USD","BK4588","LU2089984988.USD","IBB","IE00BKVL7J92.USD","LU0320765992.SGD","LU1037948897.HKD","SG9999015986.USD","LU1061106388.HKD","LU2357627491.SGD","SG9999015952.SGD","BK4568","LU0859254822.USD","LU0109394709.USD","SG9999015945.SGD","MEDI","BBH","BK4139","BMED","BK4583","LU1037948541.HKD","BK4566","LU1066053197.SGD","LU1585245621.USD","SG9999015978.USD","LU0889565916.HKD","LU0234570918.USD","TBXU","BK4585","LU0058720904.USD","LU0114720955.EUR","LU1934455863.HKD","BK4532","IE00B7SZLL34.SGD","LU0861579265.USD","LU0289739699.SGD","LU0823416689.USD","LU2324357040.USD","LU1057294990.SGD","LU0965509101.SGD","LU1674673691.USD","IE00B19Z3B42.SGD","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222504","title":"Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222504","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222504?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:00","pubTimestamp":1787554851,"startTime":"0","endTime":"0","summary":"Daiichi Sankyo names Ken Keller chief commercialization officer, effective April 2027Daiichi Sankyo named Ken Keller chief commercialization officer, effective April 1, 2027, to run a new globally int","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLbyMxfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU1057294990.SGD","PBE","LU1571399168.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU0889565916.HKD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2089984988.USD","AMGN","LU2242652126.USD","BK4139","LU2468319806.SGD","LU1023059063.AUD","LU2112291526.USD","BK4585","IBB","PJP","LU1983299246.USD","LU0289739699.SGD","BBH","LU0058720904.USD","BK4566","IE0002141913.USD","TBXU","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2242646821.SGD","IE00BJJMRZ35.SGD","BK4533","LU0109394709.USD","BK4581","BK4599","BK4588","SG9999001440.SGD","LU0868494617.USD","LU0122379950.USD","BK4534","IBBQ","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661228075","title":"Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228075","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228075?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:29","pubTimestamp":1787542174,"startTime":"0","endTime":"0","summary":"Earlier in August 2026, VIAVI Solutions launched Vertex 6.0, an enhanced channel emulation platform with 400 MHz instantaneous bandwidth and support for carrier frequencies up to 23.6 GHz, targeting next-generation 6G and Wi‑Fi 7/8 testing and integrating real-world RF propagation into lab environments.\nThis upgrade, the first since acquiring Spirent’s high-speed Ethernet, network security and channel emulation testing business, positions Vertex 6.0 as a modular RF digital twin platform...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1674673428.USD","IE0002141913.USD","SG9999001176.SGD","LU0432979614.USD","LU2417539215.USD","PBE","LU2065171402.SGD","CHAT","LU2065171311.SGD","LU0417517546.SGD","IBBQ","GNMX","LU2236285917.USD","BBH","TBXU","BK4567","IDNA","IBB","LU1069344957.HKD","LU2065170008.USD","QTOC","VRTX","VTHR","IE00B4R5TH58.HKD","LU2362540622.SGD","VERX","LU0240877869.USD","IE00B2B36J28.USD","LU1585245621.USD","LU0205194284.USD","BIB","LU0889565916.HKD","VIAG","VIAV","BK4585","LU2089984988.USD","ARTY","LU0109394709.USD","LU0061475181.USD","LU0234570918.USD","LU1559883803.SGD","SG9999013999.USD","AIPO","AGIX","IE00B19Z9Z06.USD","LU1093756325.SGD","BK4532","LU2462157665.USD","BK4023","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU2362540622.SGD","LU0859254822.USD","BK4599","LU0868494617.USD","LU2106854487.HKD","LU1430594728.SGD","IE00B7SZLL34.SGD","BMED","LU0154245756.USD","IE00BKVL7J92.USD","SG9999013999.USD","LU1974910355.USD","XBI","LU1061106388.HKD","LU1023059063.AUD","LU1983299246.USD","LU0234570918.USD","LU1093756325.SGD","LU0417517546.SGD","LU1066051498.USD","IE00B894F039.SGD","BK4007","SG9999001440.SGD","LU1934455863.HKD","AMGN","BK4532","LU0882574055.USD","04332","SGXZ57979304.SGD","LU0154245673.USD","GILD","IE00B19Z3581.USD","IE0009355771.USD","LU2468319806.SGD","LU0823416689.USD","LU0079474960.USD","BBH","LU0861579265.USD","LU0053666078.USD","LU2089984988.USD","IE00BN0W2T93.GBP","LU1674673691.USD","SG9999015978.USD","LU2456880835.USD","LU1035775433.USD","SG9999001176.USD","BK4566","LU1066053197.SGD","BK4550","LU2112291526.USD","IE00B3T34201.USD","BK4581","IE00BN0W2V16.EUR","BK4585","LU2242652126.USD","IE0002270589.USD","IE00B2B36J28.USD","LU0432979614.USD","LU1093756168.USD","BIB","LU2237438978.USD","BK4583","LU0965509283.SGD","LU1585245621.USD","LU2362541273.HKD","LU1917777945.USD","LU0823434740.USD","MEDI","BK4533","LU2236285917.USD","LU2417539215.USD","IE00BJJMRZ35.SGD","IBB","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","LU0965509101.SGD","SG9999015945.SGD","IE00B4R5TH58.HKD","BK4588","TMED","LU0965509010.AUD","IE00BN0W2W23.USD","LU2023250504.SGD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU1037948897.HKD","IBBQ","JAZZ","REGN","SG9999015986.USD","BK4567","BK4534","LU0965508806.USD","LU2324357040.USD","LU1839511570.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","IE00B19Z9Z06.USD","LU0061475181.USD","LU0109394709.USD","LU2242646821.SGD","PJP","LU2087621335.USD","LU0256863811.USD","IE00BFTCPJ56.SGD","SG9999015952.SGD","IDNA","LU1069344957.HKD","LU0889565916.HKD","LU0320765992.SGD","BK4568","LU0122379950.USD","VRTX","GNMX","LU0114720955.EUR","BK4139","BK4578","LU2462157665.USD","IE00BZ9MQY76.HKD","LU0289739699.SGD","LU1778281490.HKD","LU2357627491.SGD","LU1037948541.HKD","LU1057294990.SGD","LU1571399168.USD","LU0823434583.USD","TBXU","SG9999001176.SGD","IE0002141913.USD","LU1934455194.USD","LU1934455277.USD","LU2362541513.USD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661187372","title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","url":"https://stock-news.laohu8.com/highlight/detail?id=2661187372","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661187372?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:22","pubTimestamp":1787354576,"startTime":"0","endTime":"0","summary":"Gilead director Jeffrey Bluestone disposes of 5,000 common shares worth $727,333.60Gilead director Jeffrey Bluestone exercised stock options on Aug. 20, 2026, acquiring 5,000 shares at USD 61.35 to US","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4cgVd7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU0965509010.AUD","SG9999015986.USD","TBXU","BBH","BIB","LU1674673691.USD","LU2468319806.SGD","BK4568","BK4588","IBBQ","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU0320765992.SGD","LU2087621335.USD","LU2357627491.SGD","BK4532","LU1430594728.SGD","LU0861579265.USD","BK4139","BK4583","LU0234570918.USD","SG9999015952.SGD","LU0882574055.USD","SG9999015978.USD","BK4566","LU1066053197.SGD","LU0289739699.SGD","LU0965508806.USD","LU2089984988.USD","LU0122379950.USD","IBB","LU1585245621.USD","IE00B19Z3581.USD","LU0965509101.SGD","LU1934455863.HKD","LU0859254822.USD","LU1023059063.AUD","LU1057294990.SGD","LU1571399168.USD","TMED","SG9999015945.SGD","GILD","LU1674673428.USD","IE00BSNM7G36.USD","LU0965509283.SGD","LU1778281490.HKD","BMED","IE00B19Z3B42.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661972042","title":"Moderna Inc. Stock Advances 8.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661972042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661972042?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:33","pubTimestamp":1787344380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 8.9% to $145.13 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.Moderna Inc. closed 17.8% below its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.24, Pfizer Inc. rose 1.0% to $28.07, and Gilead Sciences Inc. rose 1.87% to $146.12.Trading volume totaled 86.7 million, compared to the 50-day average of 13.0 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965508806.USD","WDNA","LU0289739699.SGD","GNOM","BK4551","LU1066053197.SGD","LU2324357040.USD","TBXU","MRNY","MEDI","LU2112291526.USD","BK4550","BBH","LU0965509283.SGD","GILD","LU1037948541.HKD","MRNX","SG9999015986.USD","IBBQ","SG9999015952.SGD","LU1430594728.SGD","BMED","LU0058720904.USD","LU2357627491.SGD","TMED","LU0823416689.USD","BK4501","IDNA","MRNA","BIB","LU1674673691.USD","LU0320765992.SGD","SG9999015978.USD","LU1934455863.HKD","LU0122379950.USD","LU0234570918.USD","BK4585","LU1839511570.USD","LGHT","BK4532","LU1585245621.USD","BK4583","LU1057294990.SGD","LU1934455194.USD","LU0861579265.USD","IBB","LU0965509010.AUD","LU1061106388.HKD","IE0002270589.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661940352","title":"Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2661940352","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661940352?lang=en_us&edition=fundamental","pubTime":"2026-08-22 01:58","pubTimestamp":1787335117,"startTime":"0","endTime":"0","summary":"Gilead declares Q3 2026 dividend of R$ 0.24 per unitGilead Sciences set a Q3 2026 distribution of R$ 0.24 per unit for BRGILDBDR 000.Last day to trade with rights: Sept. 11, 2026.Payment date: Oct. 5,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL12Yy9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU1037948541.HKD","LU1037948897.HKD","LU0859254822.USD","BK4583","LU1674673428.USD","IE00B3T34201.USD","BK4585","BMED","LU0823416689.USD","GILD","LU2468319806.SGD","BK4588","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU2324357040.USD","IE0002270589.USD","LU2357627491.SGD","TMED","LU0122379950.USD","LU0965508806.USD","BK4568","LU0320765992.SGD","LU0965509283.SGD","LU2112291526.USD","SG9999015986.USD","IBB","LU0114720955.EUR","LU0889565916.HKD","BK4578","IBBQ","BK4532","LU1430594728.SGD","TBXU","LU0882574055.USD","LU0965509010.AUD","LU1585245621.USD","LU1674673691.USD","IE00B7SZLL34.SGD","LU1066053197.SGD","BK4139","IE00BSNM7G36.USD","BIB","LU0965509101.SGD","LU1061106388.HKD","MEDI","BK4550","BBH","LU1023059063.AUD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661887294","title":"Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661887294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661887294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:34","pubTimestamp":1787330049,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s new Phase 3 DeLLphi-315 study tests its cancer drug tarlatamab in pe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1061106388.HKD","LU2089984988.USD","IE00BJJMRZ35.SGD","BBH","LU1057294990.SGD","LU2468319806.SGD","PJP","BIB","LU1571399168.USD","BK4533","SG9999001440.SGD","LU2242646821.SGD","LU0058720904.USD","IBB","LU0320765992.SGD","LU0868494617.USD","PBE","IE00BFTCPJ56.SGD","BK4566","IE0002141913.USD","IE0009355771.USD","LU0122379950.USD","LU2112291526.USD","LU2242652126.USD","BK4534","LU0109394709.USD","BK4581","LU0889565916.HKD","AMGN","BK4585","LU0289739699.SGD","BK4139","IBBQ","LU1023059063.AUD","TBXU","BK4599","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4588","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}